Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Iwao Yamada
Observed names:
I Yamada,
I. Yamada,
Iwao YAMADA,
Iwao Yamada,
Institutions:
Brigham and Women's Hospital,
Harvard University,
Kowa (Japan)
Observed institutions:
Brigham and Women's Hospital,
Harvard University,
Johns Hopkins University,
Keio University,
Johns Hopkins Medicine,
Kowa (Japan)
show all 6
OpenAlex ID:
A5111690150
Dynamin-Related Protein 1 Inhibition Attenuates Cardiovascular Calcification in the Presence of Oxidative Stress
2017
·
Maximillian A. Rogers
, Natalia Maldonado
, et al.
·
Circulation Research
·
123
PDF
Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization
2003
·
H. Fujino
, I. Yamada
, et al.
·
Xenobiotica
·
96
Cystathionine γ-lyase Accelerates Osteoclast Differentiation
2013
·
Takahiro Itou
, Natalia Maldonado
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
37
PDF
Studies on the Metabolic Fate of NK-104, a New Inhibitor of HMG-CoA Reductase. (5). In Vitro Metabolism and Plasma Protein Binding in Animals and Human.
1999
·
Hideki FUJINO
, Iwao YAMADA
, et al.
·
Drug Metabolism and Pharmacokinetics
·
34
PDF
Metabolic Fate of Pitavastatin (NK-104), a New Inhibitor of 3-Hydroxy-3-methyllutaryl Coenzyme A Reductase
2011
·
Hideki Fujino
, Iwao Yamada
, et al.
·
Arzneimittelforschung
·
31
Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: similarities and difference in the metabolism of pitavastatin in monkeys and humans
2003
·
I. Yamada
, H. Fujino
, et al.
·
Xenobiotica
·
29
Metabolic Fate of Pitavastatin, a New Inhibitor of HMG-CoA Reductase—Effect of cMOAT Deficiency on Hepatobiliary Excretion in Rats and of mdr 1a/b Gene Disruption on Tissue Distribution in Mice
2002
·
Hideki Fujino
, Iwao Yamada
, et al.
·
Drug Metabolism and Pharmacokinetics
·
27
Pd-Catalyzed coupling reaction of glycosylamines with 6-chloropurines: Synthesis of 6-(β-d-mannopyranosylamino)-9H-purine and its β-d-gluco isomer, N-glycoside models for spicamycin and septacidin
1999
·
Noritaka Chida
, Tamotsu Suzuki
, et al.
·
Tetrahedron Letters
·
27
Simultaneous determination of taxol and its metabolites in microsomal samples by a simple thin-layer chromatography radioactivity assay — inhibitory effect of NK-104, a new inhibitor of HMG-CoA reductase
2001
·
Hideki Fujino
, Iwao Yamada
, et al.
·
Journal of Chromatography B Biomedical Sciences and Applications
·
25
Interaction Between Fibrates and Statins - Metabolic Interactions With Gemfibrozil
2003
·
Hideki Fujino,
, Iwao Yamada,
, et al.
·
Drug metabolism and drug interactions
·
23
Studies on the Interaction between Fibrates and Statins Using Human Hepatic Microsomes
2011
·
Hideki Fujino
, Syunsuke Shimada
, et al.
·
Arzneimittelforschung
·
17
Multiorgan Systems Study Reveals Igfbp7 as a Suppressor of Gluconeogenesis after Gastric Bypass Surgery
2019
·
Naoaki Arima
, Yusuke Sasaki
, et al.
·
Journal of Proteome Research
·
4
Studies on the metabolic fate of itavastatin, a new inhibitor of HMG-CoA reductase-in vitro metabolism
2000
·
H Fujino
, I Yamada
, et al.
·
Atherosclerosis
·
4
Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Is the metabolism of pitavastatin in monkey similar to that in human?
2001
·
Iwao Yamada
, Hideki Fujino
, et al.
·
Drug Metabolism and Pharmacokinetics
·
1
Abstract 663: Nuclear RSK1 Induces Pro-inflammatory Activation of Macrophages through STAT1 Phosphorylation at Ser727
2018
·
Keishi Nihira
, Arda Halu
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
Abstract 16983: Inhibition of Dynamin-Related Protein 1 Accelerates Vascular Calcification in apoE-Deficient Mice through AKT Activation
2014
·
Maximillian Rogers
, Natalia Maldonado
, et al.
·
Circulation
Abstract 18687: PARP9 and PARP14 are Novel Regulators of Macrophage Activation
2014
·
Hiroshi Iwata
, Hideo Yoshida
, et al.
·
Circulation
2P-0571 Metabolic fate of pitavastatin - Interaction between fibrates and statins
2003
·
H. Fujino
, S. Shimada
, et al.
·
Atherosclerosis Supplements
2P-0572 Metabolic fate of pitavastatin - UDP-glucuronosyltransferase involved the lactonization in human and animals
2003
·
S. Shimada
, H. Fujino
, et al.
·
Atherosclerosis Supplements
2P-0575 Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase - Experiments on the carrier-mediated transport systems in liver
2003
·
S. Shimada
, H. Fujino
, et al.
·
Atherosclerosis Supplements
Studies on metabolic fate of pitavastatin (NK-104), a new inhibitor of HMG-CoA reductase-Does glucronidation mediate the lactonization of pitavastatin?
2001
·
Hideki Fujino
, Iwao Yamada
, et al.
·
Drug Metabolism and Pharmacokinetics
Show more works
View as search
Works count:
21
Citation count:
478
H-index:
11
I10-index:
11
Year
Topic
Type